Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Clinical trial NCT03112590 · COMPLETED

Trial details

NCT number: NCT03112590
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer, Male Breast Cancer Female HER2-positive Breast Cancer

Start date: 2017-06-23
Primary completion: 2021-03-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.